Blogs
Catalyst to Moderate DIA 2025 Panel on Enhancing Innovation in CGT Clinical Trials for Rare Disease
Join us for this dynamic conversation on Monday, June 16th, from 2:15–3:15 PM at DIA. We’d love to connect if you’ll be attending!
Catalyst to attend FDLI 2025 Annual Conference
If you are attending the FDLI conference, we would love to chat - reach out to us on LinkedIn!
The Catalyst Team shows support on Rare Disease Day
Being rare is often a blessing: a rare gem stands out from a pile of stones, a rare talent can garner prestige and success, and a rare personality can make for an influential leader or a cultural icon.
Catalyst advances women’s health in new LinkedIn article
On Tuesday, Catalyst’s Taryn Serman and Nancy Myers, together with industry leaders, published the following article regarding women’s health on LinkedIn.
Government Shutdown 101: What to Expect
March 14th is approaching fast, and it increasingly looks like politicians are driving us toward another government shutdown.
Expected FDA Impact of a Government Shutdown
Critically, the critical public health mission and user fees are the buffer for FDA when a shutdown occurs. Below, we will delve into how a shutdown may look for the FDA under the Trump administration.
